Alexandria, VA – Join Program Chairs Anna Mae Diehl, MD, FAASLD, Mazen Noureddin, MD, MHSc, and AASLD President Ray Kim, MD, MBA, FAASLD to learn about the latest groundbreaking discoveries and practical treatment methods for Metabolic Dysfunction Associated Steatotic Liver Disease (MASLD) at the AASLD Emerging Topic Conference (ETC): Precision Medicine in MASLD held on March 8-9 in Las Vegas, NV.
This event unites physicians, scientists, and allied health professionals at the forefront of Precision Medicine in MASLD. The conference aims to evaluate the role of OMICs technologies in relation to MASLD care, explore novel ‘wet’ and ‘dry’ biomarkers in diagnosis and risk assessment, and uncover strategies and best practices for applying precision medicine, amongst other topics. View the two-day program.
AASLD and its members are proud to have been one of the leading multinational liver societies that developed and finalized the new NAFLD nomenclature for liver disease, which was announced in June 2023: Steatotic Liver Disease. AASLD is committed to providing extensive resources and cutting-edge educational opportunities, including the upcoming Emerging Topic Conference that will provide attendees with the latest information on precision medicine in MASLD.
Program Chairs:
Anna Mae Diehl, MD, FAASLD
Mazen Noureddin, MD, MHSc
W. Ray Kim, MD, MBA, FAASLD
Speakers:
Alina Allen, MD
Arun Sanyal, MD, FAASLD
Cynthia Behling, MD, PhD
Dina Tiniakos, MD, PhD, FRCPath
Elisabeth Bugianesi, MD, PhD
Jasmohan Bajaj, MD, FAASLD
Kathleen Corey, MD, MPH, MMSc
Lisa VanWagner, MD, MS
Liz Speliotes, MD, PhD, MPH
Mary E. Rinella, MD, FAASLD
Meena Bansal, MD, FAASLD
Megan Gray, MD
Michelle Long, MD, MSc
Mustafa Bashir, MD
Naga Chalasani, MD, FAASLD
Quentin Anstee, MBBS, PhD, FRCP
Rohit Loomba, MD, MHSc, FAASLD
Sam Klein, MD
Samer Gawrieh, MD
Silvia Sookoian, MD, PhD, FAASLD
Stephen Harrison, MD, FAASLD
Vincent Wong, MD
Yaron Rotman, MD, MSc, FAASLD
###
About AASLD
AASLD is the leading organization of clinicians, researchers and allied health professionals committed to preventing and curing liver disease. The work of our members has laid the foundation for the development of drugs used to treat patients with viral hepatitis. Access to care and support of liver disease research are at the center of AASLD’s advocacy efforts. To learn more, visit www.aasld.org.